Rashid Giniatullin Selected Research

Serotonin (5 Hydroxytryptamine)

1/2022	5-hydroxytryptamine in migraine: The puzzling role of ionotropic 5-HT3 receptor in the context of established therapeutic effect of metabotropic 5-HT1 subtypes.
1/2020	Antidromic Spike Propagation and Dissimilar Expression of P2X, 5-HT, and TRPV1 Channels in Peripheral vs. Central Sensory Axons in Meninges.
1/2020	Modeling a Nociceptive Neuro-Immune Synapse Activated by ATP and 5-HT in Meninges: Novel Clues on Transduction of Chemical Signals Into Persistent or Rhythmic Neuronal Firing.
1/2017	Serotonergic mechanisms of trigeminal meningeal nociception: Implications for migraine pain.
3/2006	Comparison of P2X and TRPV1 receptors in ganglia or primary culture of trigeminal neurons and their modulation by NGF or serotonin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rashid Giniatullin Research Topics

Disease

34	Migraine Disorders (Migraine) 01/2024 - 06/2006
34	Pain (Aches) 01/2024 - 01/2003
9	Headache (Headaches) 01/2022 - 11/2013
5	Chronic Pain 03/2021 - 02/2008
4	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2018 - 06/2011
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2016 - 06/2011
3	Alzheimer Disease (Alzheimer's Disease) 06/2022 - 02/2014
3	Inflammation (Inflammations) 01/2022 - 06/2011
3	Hyperhomocysteinemia 01/2022 - 01/2015
3	Hyperalgesia 01/2022 - 01/2016
3	Migraine with Aura (Familial Hemiplegic Migraine) 01/2021 - 08/2010
3	Epilepsy (Aura) 01/2019 - 01/2017
2	Neoplasms (Cancer) 11/2023 - 01/2017
2	Neuroinflammatory Diseases 01/2020 - 01/2019
2	Seizures (Absence Seizure) 01/2019 - 01/2017
1	Peripheral Nervous System Diseases (PNS Diseases) 11/2023
1	Neuralgia (Stump Neuralgia) 11/2023
1	Breast Neoplasms (Breast Cancer) 11/2023
1	Photophobia (Light Sensitivity) 01/2022
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2022
1	Hypoxia (Hypoxemia) 10/2019
1	Drug Resistant Epilepsy 01/2019
1	Tuberous Sclerosis (Bourneville's Disease) 01/2019
1	Migraine without Aura (Common Migraine) 01/2018
1	Disease Progression 10/2017
1	Nervous System Diseases (Neurological Disorders) 02/2017

Drug/Important Bio-Agent (IBA)

21	Adenosine Triphosphate (ATP)IBA 01/2020 - 01/2003
7	Calcitonin Gene-Related PeptideIBA 01/2021 - 06/2006
6	Analgesics (Analgesic Drugs)IBA 04/2022 - 06/2006
6	HomocysteineIBA 01/2022 - 04/2014
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2013
5	Serotonin (5 Hydroxytryptamine)IBA 01/2022 - 03/2006
5	Purinergic P2X3 ReceptorsIBA 01/2011 - 06/2006
4	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 04/2023 - 01/2018
4	Monoacylglycerol LipasesIBA 04/2023 - 01/2018
4	EndocannabinoidsIBA 04/2023 - 01/2018
4	Nitroglycerin (Dynamite)FDA LinkGeneric 01/2022 - 11/2013
4	Capsaicin (Zostrix)FDA Link 03/2021 - 03/2006
3	N-Methylaspartate (NMDA)IBA 01/2024 - 01/2017
3	Proteins (Proteins, Gene)FDA Link 04/2023 - 05/2014
3	EnzymesIBA 04/2022 - 01/2018
3	Ion Channels (Ion Channel)IBA 04/2022 - 05/2020
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2022 - 01/2016
3	NeuropeptidesIBA 02/2017 - 06/2006
3	Nerve Growth Factor (NGF)IBA 02/2008 - 03/2006
2	anandamide (arachidonylethanolamide)IBA 04/2023 - 04/2022
2	Coloring Agents (Dyes)IBA 01/2023 - 01/2019
2	Glutamic Acid (Glutamate)FDA Link 01/2022 - 01/2017
2	CollagenIBA 01/2022 - 01/2017
2	CannabinoidsIBA 01/2021 - 01/2018
2	Formaldehyde (Formol)FDA Link 01/2021 - 01/2016
2	PlasticsIBA 01/2020 - 03/2006
2	Adenosine (Adenocard)FDA LinkGeneric 01/2019 - 01/2018
2	diadenosine tetraphosphateIBA 01/2019 - 01/2016
2	Cholinergic Agents (Cholinergics)IBA 02/2017 - 01/2017
2	Acetylcholine (Acetylcholine Chloride)FDA Link 02/2017 - 01/2017
2	Carbachol (Carbastat)FDA Link 02/2017 - 01/2017
2	Amyloid (Amyloid Fibrils)IBA 01/2016 - 02/2014
2	Amino Acids FDA Link 01/2016 - 01/2015
1	Deoxycholic Acid (Sodium Deoxycholate)IBA 11/2023
1	Paclitaxel (Taxol)FDA LinkGeneric 11/2023
1	glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA 04/2023
1	FM1 43IBA 01/2023
1	Amyloid beta-PeptidesIBA 06/2022
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 04/2022
1	Glutamate Receptors (Glutamate Receptor)IBA 01/2022
1	MagnesiumIBA 01/2022
1	Tryptamines (Triptans)IBA 01/2022
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2022
1	Glycoproteins (Glycoprotein)IBA 01/2022
1	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 01/2022
1	CytokinesIBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	LigandsIBA 01/2022
1	Serotonin 5-HT3 Receptor AntagonistsIBA 01/2022
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022
1	HydrolasesIBA 01/2021
1	incobotulinumtoxinA FDA Link 01/2021
1	Type A Botulinum Toxins (Botox)FDA Link 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Sodium Channels (Sodium Channel)IBA 01/2021
1	GasotransmittersIBA 01/2020
1	sodium bisulfide (NaHS)IBA 01/2020
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2020
1	Purinergic P2X7 ReceptorsIBA 01/2020
1	CalciumIBA 01/2019
1	PolyphosphatesIBA 01/2019
1	trans-sodium crocetinate (crocetin)IBA 01/2019
1	diadenosine- 5',5'''- P(1),P(4)- (beta,beta'- methylene)tetraphosphonateIBA 01/2019
1	Phosphotransferases (Kinase)IBA 12/2017
1	AntioxidantsIBA 10/2017
1	Nicotine FDA Link 02/2017
1	hydroxide ionIBA 01/2017
1	Diphosphonates (Bisphosphonates)IBA 01/2017

Therapy/Procedure

6	Therapeutics 01/2022 - 10/2017
4	Analgesia 04/2022 - 01/2011
1	Cell Transplantation 01/2022
1	Injections 01/2021
1	Electroacupuncture 05/2020
1	Induced Hyperthermia (Thermotherapy) 10/2019